Dilution profile // every instrument, one screen, from SEC filings

PALISADE BIO, INC. (PALI)

CIK 1357459 · all EDGAR filings →

Overall dilution risk
HIGHworst of 4 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
Offering ability
HIGH$435M registered
= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)
registered capacity, not remaining: amounts already taken down are not subtracted yet
Overhead supply
MEDIUMwarrants = 30% of O/S
= warrant shares outstanding divided by current shares outstanding (bands: 20% / 50%)
warrants only; converts, ATMs and equity lines are not in free structured data, so the true overhead is AT LEAST this
Historical dilution
HIGH+2442% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
a reverse-split-sized cliff is in this window; read the chart
Cash need
LOW~138.5 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2020-10-312026-08-06

Latest: 174.3M shares as of Aug 6, 2026 (10-Q). Share count fell from 77.1M to 4.5M between Nov 10, 2022 and Mar 15, 2023, a pattern consistent with a reverse split (roughly 1-for-17); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.

Cash runway

Self-funding

generates cash

Full breakdown: cash runway tool · source filing →

Warrants

Warrants outstanding: 51.7M underlying shares, as reported Jun 30, 2026 (10-Q).

Reported exercise price: $0.66 (aggregate figure as tagged; individual tranches vary).

Balance-sheet fair value of warrants: $4.7M as of Jun 30, 2025.

Down-round (price protection) accounting has been tagged in this filer’s XBRL: some instrument carries repricing protection. Which tranche requires reading the exhibits.

Rough fully diluted estimate: 225.9M = 174.3M O/S + 51.7M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.

Convertible notes

No convertible-note facts tagged in the 10-Q filed Aug 10, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Fully diluted build-up

Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.

Shares outstanding174.3MAug 6, 2026
+ Warrants (aggregate, as tagged) (if exercised)51.7MJun 30, 2026
Fully diluted estimate225.9M+29.6% vs O/S

Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.

Registrations and offerings

Registered offering capacity on live registrations: $434.6Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

S-3May 12, 2026$300.0M registeredfiling →
S-1Sep 29, 2025$126.4M registeredfiling →
S-3Aug 15, 2025$8.2M registeredfiling →

Last 12 months: 1 executed · 4 registered.

EFFECTIVEMay 21, 2026SEC declared a registration effective — selling can beginEFFECT
REGISTEREDMay 12, 2026S-3 registration — capacity to sell shares, not a sale yetS-3
EXECUTEDOct 2, 2025Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4
REGISTEREDOct 1, 2025S-1MEF registration — capacity to sell shares, not a sale yetS-1MEF
EFFECTIVESep 30, 2025SEC declared a registration effective — selling can beginEFFECT
REGISTEREDSep 29, 2025S-1 registration — capacity to sell shares, not a sale yetS-1
EFFECTIVEAug 28, 2025SEC declared a registration effective — selling can beginEFFECT
REGISTEREDAug 15, 2025S-3 registration — capacity to sell shares, not a sale yetS-3
EXECUTEDJul 25, 2025Unregistered share sale disclosed (8-K item 3.02)8-K
WITHDRAWNJun 12, 2025Registration withdrawnRW
REGISTEREDMay 27, 2025S-1 registration — capacity to sell shares, not a sale yetS-1
UPDATEDec 17, 2024Prospectus update — often a resale registration, not necessarily new capital424B3

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full PALI workspace